Molecular Pathology
We utilise the latest research findings to assist clinicians with personalised cancer treatments and in combating complex diseases.
Fast and Precise Diagnostics
Rapid turnaround times and adherence to German standards of precision and accuracy.
To-the-Point, High-Quality Diagnostic Reports
High-quality reports that summarise relevant information concisely and precisely.
Evaluation by an Interdisciplinary Team
Findings are evaluated by a team comprising oncologists and pathologists.
Direct and Individual Consultation
Promptly available for professional consultations and personalised advice.
Tumor Tissue
Hot Spot Panel
Analysis of known hotspots to indicate approved therapies using Next-Generation Sequencing (NGS).
PanCancer Panel
A comprehensive genetic testing approach that simultaneously analyses a broad spectrum of genes associated with various cancer types. This identifies potential mutations and guides personalised treatment strategies, including off-label use and participation in available clinical studies (NGS).
MammaPrint
Gene expression analysis for breast cancer patients to assess the risk of metastasis and thus determine the necessity for chemotherapy.
Liquid Biopsy
Hot Spot Panel
We utilise Next-Generation Sequencing (NGS) and digital droplet PCR (ddPCR) for the mutation analysis of cell-free DNA in the blood.
MRD Diagnostic via ddPCR
This method detects very low frequencies using digital droplet PCR (ddPCR) to measure minimal residual disease.
Connect With Us
